Market Closed -
Other stock markets
|
After market 11:20:00 am | |||
2,041 DKK | +0.74% | 2,041 | 0.00% |
May. 15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
May. 15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.29% | 19.07B | |
+8.79% | 114B | |
+11.32% | 104B | |
-12.65% | 22.41B | |
-1.05% | 22.28B | |
-38.29% | 18B | |
-3.30% | 17.89B | |
+7.91% | 14.28B | |
+35.49% | 12.55B | |
-24.99% | 8.45B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment